Home Company Team Portfolio News Dedicated to biomedical financing and active management Contact Us OUR STORY Founded in 1979, Sanderling is among the oldest investment firms dedicated to building new biomedical companies. We demonstrate that significant companies are best built in close working partnerships with entrepreneurs. CHECK US OUT HOW WE CAN HELP Our unique approach combines a specialized investment focus with active management and long-term commitment to ensure the highest rates of return for both its entrepreneurs and investors. LEARN MORE SPECIALIZATION Small molecule therapeutics Biologics and vaccines Drug delivery Platform technologies Medical devices SEE ALL RECENT NEWS July 26, 2021 - In Memoriam, Robert McNeil (1943 – 2021) READ MORE June 29, 2021 - Glycomine’s Natural History Study Informs Potentially Lifesaving Update to Standard of Care for PMM2-CDG Patients READ MORE June 29, 2021 - Should patients with Phosphomannomutase 2-CDG (PMM2-CDG) be screen for adrenal insufficiency? READ MORE SAN MATEO OFFICE 1300 S. El Camino Real Suite 203 San Mateo, CA 94402 650-401-2000 F: 650-375-7077 info@sanderling.com MONTREAL, QUEBEC OFFICE 1010 Sherbrooke St. W. Suite 408 Montreal, Quebec H3A 2R7 514-564-6474 info@sanderling.com OUR COMPANY Home About Us Therillia News ©2021 Sanderling Ventures. All Rights Reserved.

Home Company Team Portfolio News CONTACT CONTACT US SUBMIT INDUSTRY SPONSORSHIPS AND AFFILIATIONS SAN MATEO OFFICE 1300 S. El Camino Real Suite 203 San Mateo, CA 94402 650-401-2000 F: 650-375-7077 info@sanderling.com MONTREAL, QUEBEC OFFICE 1010 Sherbrooke St. W. Suite 408 Montreal, Quebec H3A 2R7 514-564-6474 info@sanderling.com OUR COMPANY Home About Us Therillia News ©2021 Sanderling Ventures. All Rights Reserved.